目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 23)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY (Page No. - 27)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
FIGURE 2 KEY INDUSTRY INSIGHTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT ANALYSIS
2.7.1 SCOPE-RELATED LIMITATIONS
2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 39)
FIGURE 9 BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 MARKET, BY AGENT TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET: REGIONAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 43)
4.1 BIO DECONTAMINATION MARKET OVERVIEW
FIGURE 14 INCREASING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET
4.2 NORTH AMERICA: MARKET, BY END USER AND COUNTRY
FIGURE 15 PHARMACEUTICAL & MEDICAL DEVICE MANUFACTURING COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 46)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 BIO DECONTAMINATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of hospital-acquired infections
5.2.1.2 Increasing number of surgical procedures
TABLE 2 US: PERCENTAGE INCREASE IN SURGERIES PERFORMED
TABLE 3 US: NUMBER OF AESTHETIC SURGERIES PERFORMED (2020 VS. 2021)
5.2.1.3 Growing outsourcing of bio decontamination services to third-party providers
5.2.1.4 Rising growth in pharmaceutical & biotechnology industry
5.2.1.5 Stringent regulatory guidelines for pharmaceutical & medical device manufacturing companies
5.2.2 RESTRAINTS
5.2.2.1 Use of manual bio decontamination methods in emerging economies
5.2.2.2 Rising adoption of single-use medical devices
5.2.2.3 Availability of alternative techniques
5.2.3 OPPORTUNITIES
5.2.3.1 Growing healthcare sector in emerging markets
5.2.3.2 Increasing establishment of pharmaceutical & medical device companies
5.2.3.3 Rising adoption of nitrogen dioxide bio decontamination
5.2.3.4 Increasing number of hospitals and healthcare facilities
5.2.4 CHALLENGES
5.2.4.1 Challenges associated with equipment & technology costs
5.2.4.2 Variability of pathogen resistance
5.2.4.3 Safety concerns regarding hazardous chemicals
5.2.5 TRENDS
5.2.5.1 Increasing focus on infection control
5.2.5.2 Adoption of eco-friendly decontamination products
5.3 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 19 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.5 TECHNOLOGY ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 INTENSITY OF COMPETITIVE RIVALRY
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 BARGAINING POWER OF SUPPLIERS
5.6.5 THREAT OF SUBSTITUTES
5.7 KEY STAKEHOLDERS & BUYING CRITERIA
5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 END USERS (%)
5.7.2 BUYING CRITERIA
FIGURE 21 KEY BUYING CRITERIA FOR END USERS
TABLE 5 KEY BUYING CRITERIA FOR END USERS
5.8 REGULATORY LANDSCAPE
TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES FOR MARKET
5.8.1 NORTH AMERICA
5.8.2 EUROPE
5.9 PATENT ANALYSIS
5.10 KEY CONFERENCES AND EVENTS
TABLE 7 LIST OF CONFERENCES AND EVENTS (2023−2024)
5.11 PRICING ANALYSIS
TABLE 8 PRICE RANGE FOR BIO DECONTAMINATION PRODUCTS
5.12 TRADE ANALYSIS
TABLE 9 IMPORT DATA FOR HS CODE 840510, BY COUNTRY, 2018-2022 (USD THOUSAND)
TABLE 10 EXPORT DATA FOR HS CODE 840510, BY COUNTRY, 2018-2022 (USD THOUSAND)
5.13 ECOSYSTEM ANALYSIS
5.13.1 ROLE IN ECOSYSTEM
5.13.2 KEY PLAYERS OPERATING IN MARKET
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

6 BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE (Page No. - 70)
6.1 INTRODUCTION
TABLE 11 MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
6.2 EQUIPMENT
6.2.1 RISING PREFERENCE FOR AUTOMATED EQUIPMENT TO DRIVE MARKET
TABLE 12 MARKET FOR EQUIPMENT, BY REGION, 2021-2028 (USD MILLION)
6.3 SERVICES
6.3.1 LOW COST OF SERVICES TO DRIVE MARKET
TABLE 13 MARKET FOR SERVICES, BY REGION, 2021-2028 (USD MILLION)
6.4 CONSUMABLES
6.4.1 RECURRING USAGE OF CONSUMABLES TO SUPPORT MARKET GROWTH
TABLE 14 MARKET FOR CONSUMABLES, BY REGION, 2021-2028 (USD MILLION)

7 BIO DECONTAMINATION MARKET, BY AGENT TYPE (Page No. - 75)
7.1 INTRODUCTION
TABLE 15 MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
7.2 HYDROGEN PEROXIDE
7.2.1 ADVANTAGES OF SAFETY AND HIGH MATERIAL COMPATIBILITY TO DRIVE MARKET
TABLE 16 MARKET FOR HYDROGEN PEROXIDE, BY REGION, 2021-2028 (USD MILLION)
7.3 CHLORINE DIOXIDE
7.3.1 EFFECTIVE STERILANT FOR MICROBIOLOGICAL CONTAMINANTS
TABLE 17 COMPARISON OF MANUAL DISINFECTION & DECONTAMINATION USING CHLORINE DIOXIDE GAS
TABLE 18 MARKET FOR CHLORINE DIOXIDE, BY REGION, 2021-2028 (USD MILLION)
7.4 PERACETIC ACID
7.4.1 UTILIZATION IN AEROSOL SYSTEMS AND CLEANROOMS TO PROPEL MARKET
TABLE 19 MARKET FOR PERACETIC ACID, BY REGION, 2021-2028 (USD MILLION)
7.5 NITROGEN DIOXIDE
7.5.1 RAPID & EFFECTIVE DECONTAMINATION AT LOW HUMIDITY LEVELS TO SUPPORT MARKET GROWTH
TABLE 20 MARKET FOR NITROGEN DIOXIDE, BY REGION, 2021-2028 (USD MILLION)

8 BIO DECONTAMINATION MARKET, BY TYPE (Page No. - 81)
8.1 INTRODUCTION
TABLE 21 MARKET, BY TYPE, 2021-2028 (USD MILLION)
8.2 CHAMBER DECONTAMINATION
8.2.1 LOWER COST AND MINIMAL POWER REQUIREMENTS TO DRIVE MARKET
TABLE 22 MARKET FOR CHAMBER DECONTAMINATION, BY REGION, 2021-2028 (USD MILLION)
8.3 ROOM DECONTAMINATION
8.3.1 REQUIREMENT OF HUMAN INTERVENTION TO RESTRAIN MARKET GROWTH
TABLE 23 ROOM DECONTAMINATION APPLICATION CATEGORIES (INDICATIVE LIST)
TABLE 24 MARKET FOR ROOM DECONTAMINATION, BY REGION, 2021-2028 (USD MILLION)

9 BIO DECONTAMINATION MARKET, BY END USER (Page No. - 85)
9.1 INTRODUCTION
TABLE 25 MARKET, BY END USER, 2021-2028 (USD MILLION)
9.2 PHARMACEUTICAL AND MEDICAL DEVICE MANUFACTURING COMPANIES
9.2.1 COMPLIANCE WITH STRINGENT REGULATIONS FOR STERILIZATION OF INSTRUMENTS TO DRIVE MARKET
TABLE 26 MARKET FOR PHARMACEUTICAL AND MEDICAL DEVICE MANUFACTURING COMPANIES, BY REGION, 2021-2028 (USD MILLION)
9.3 LIFE SCIENCES AND BIOTECHNOLOGY RESEARCH ORGANIZATIONS
9.3.1 RISING BIOTECHNOLOGY RESEARCH AND UTILIZATION OF DECONTAMINATORS IN CLEANROOMS TO DRIVE MARKET
TABLE 27 MARKET FOR LIFE SCIENCES AND BIOTECHNOLOGY RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
9.4 HOSPITALS AND HEALTHCARE FACILITIES
9.4.1 INCREASING NUMBER OF HOSPITAL-ACQUIRED INFECTIONS AND SURGICAL PROCEDURES TO DRIVE MARKET
TABLE 28 MARKET FOR HOSPITALS AND HEALTHCARE FACILITIES, BY REGION, 2021-2028 (USD MILLION)

10 BIO DECONTAMINATION MARKET, BY REGION (Page No. - 91)
10.1 INTRODUCTION
TABLE 29 MARKET, BY REGION, 2021-2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: BIO DECONTAMINATION MARKET SNAPSHOT
TABLE 30 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 31 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 32 NORTH AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 33 NORTH AMERICA: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 34 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.1 US
10.2.1.1 Increasing number of surgical procedures to drive market
TABLE 35 US: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 36 US: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 37 US: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 38 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising investments in healthcare to drive market
TABLE 39 CANADA: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 40 CANADA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 41 CANADA: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 42 CANADA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 43 EUROPE: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 44 EUROPE: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 45 EUROPE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 46 EUROPE: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 47 EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Implementation of mandates associated with sterilization of healthcare equipment to drive market
TABLE 48 GERMANY: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 49 GERMANY: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 50 GERMANY: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 51 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Increasing healthcare expenditure and implementation of regulatory guidelines to drive market
TABLE 52 UK: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 53 UK: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 54 UK: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 55 UK: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Favorable government initiatives for adoption of sterilization services to drive market
TABLE 56 FRANCE: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 57 FRANCE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 58 FRANCE: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 59 FRANCE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising growth in pharmaceutical & biotechnology industry to drive market
TABLE 60 ITALY: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 61 ITALY: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 62 ITALY: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 63 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising expansion of healthcare facilities to support market growth
TABLE 64 SPAIN: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 65 SPAIN: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 66 SPAIN: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 67 SPAIN: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 68 REST OF EUROPE: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 69 REST OF EUROPE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 70 REST OF EUROPE: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 71 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
FIGURE 23 ASIA PACIFIC: BIO DECONTAMINATION MARKET SNAPSHOT
TABLE 72 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 73 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 76 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 High growth in pharmaceutical industry to drive market
TABLE 77 JAPAN: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 78 JAPAN: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 79 JAPAN: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 80 JAPAN: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increasing growth in medical device manufacturing industry to drive market
TABLE 81 CHINA: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 82 CHINA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 83 CHINA: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 84 CHINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Establishment of key medical manufacturing companies to drive market
TABLE 85 INDIA: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 86 INDIA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 87 INDIA: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 88 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 89 REST OF ASIA PACIFIC: BIO DECONTAMINATION MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 90 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 91 REST OF ASIA PACIFIC: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 92 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
10.4.5 ASIA PACIFIC: RECESSION IMPACT
10.5 REST OF THE WORLD
TABLE 93 REST OF THE WORLD: MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
TABLE 94 REST OF THE WORLD: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 95 REST OF THE WORLD: MARKET, BY AGENT TYPE, 2021-2028 (USD MILLION)
TABLE 96 REST OF THE WORLD: MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 128)
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 97 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS
FIGURE 24 BIO DECONTAMINATION MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS
11.4 MARKET SHARE ANALYSIS
TABLE 98 MARKET: INTENSITY OF COMPETITIVE RIVALRY
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 25 MARKET: COMPANY EVALUATION MATRIX (GLOBAL)
11.6 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 26 MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS
11.7 COMPANY FOOTPRINT ANALYSIS
TABLE 99 OVERALL FOOTPRINT OF COMPANIES
TABLE 100 REGIONAL FOOTPRINT OF COMPANIES
TABLE 101 PRODUCT FOOTPRINT OF COMPANIES
11.8 COMPETITIVE BENCHMARKING
TABLE 102 BIO DECONTAMINATION MARKET: DETAILED LIST OF KEY SMES/STARTUPS
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 103 KEY PRODUCT LAUNCHES AND APPROVALS (2020−2023)
11.9.2 DEALS
TABLE 104 KEY DEALS (2020−2023)
11.9.3 OTHER DEVELOPMENTS
TABLE 105 OTHER DEVELOPMENTS (2020−2023)

12 COMPANY PROFILES (Page No. - 140)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 STERIS PLC
TABLE 106 STERIS PLC: BUSINESS OVERVIEW
FIGURE 27 STERIS PLC: COMPANY SNAPSHOT (2022)
12.1.2 ECOLAB
TABLE 107 ECOLAB: BUSINESS OVERVIEW
FIGURE 28 ECOLAB: COMPANY SNAPSHOT (2022)
12.1.3 TOMI ENVIRONMENTAL SOLUTIONS, INC.
TABLE 108 TOMI ENVIRONMENTAL SOLUTIONS, INC.: BUSINESS OVERVIEW
FIGURE 29 TOMI ENVIRONMENTAL SOLUTIONS, INC.: COMPANY SNAPSHOT (2022)
12.1.4 JCE BIOTECHNOLOGY
TABLE 109 JCE BIOTECHNOLOGY: BUSINESS OVERVIEW
12.1.5 FEDEGARI AUTOCLAVI S.P.A
TABLE 110 FEDEGARI AUTOCLAVI S.P.A.: BUSINESS OVERVIEW
12.1.6 ZHEJIANG TAILIN BIOENGINEERING CO., LTD.
TABLE 111 ZHEJIANG TAILIN BIOENGINEERING CO., LTD.: BUSINESS OVERVIEW
12.1.7 HOWORTH AIR TECHNOLOGY LIMITED
TABLE 112 HOWORTH AIR TECHNOLOGY LIMITED: BUSINESS OVERVIEW
12.1.8 SOLIDFOG TECHNOLOGIES
TABLE 113 SOLIDFOG TECHNOLOGIES: BUSINESS OVERVIEW
12.1.9 CLORDISYS SOLUTIONS, INC.
TABLE 114 CLORDISYS SOLUTIONS, INC.: BUSINESS OVERVIEW
12.1.10 AMIRA SRL
TABLE 115 AMIRA SRL: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 NOXILIZER, INC.
12.2.2 TECOMAK
12.2.3 DIOP GMBH & CO. KG
12.2.4 AM INSTRUMENTS SRL
12.2.5 ALLEN & COMPANY ENVIRONMENTAL SERVICES
12.2.6 SYCHEM LIMITED
12.2.7 CONTROLLED CONTAMINATION SERVICES
12.2.8 KLENZAIDS
12.2.9 CURIS DECONTAMINATION
12.2.10 IHSS LTD.
12.2.11 METALL+PLASTIC GMBH
12.2.12 BIO DECONTAMINATION LTD.
12.2.13 SYNTEGON TECHNOLOGY GMBH
12.2.14 THE ECOSENSE COMPANY
12.2.15 REATORG
12.2.16 CLEAMIX
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 171)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS